8-K
Current Report
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0000930413-08-006327
Agreement ended · Executive or director change
- Item 1.02 Termination of a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading c55487_8-k.htm…